Abogen Biosciences
PrivateLast Round
Grant
Feb 4, 2026
Est. Valuation
$3.1B
Total Funding Raised
$1.13B
Company Overview
AbogenBio is a biotechnology company specializing in the development of mRNA drugs and vaccines for infectious diseases, offering a comprehensive drug development pipeline that encompasses design, development, and production for the efficient delivery of new therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abogen Biosciences Comps
Public and private peers based on sector, stage, and business model.
Abogen Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 4, 2026 | ||||
| Series C Extension | Nov 29, 2021 | ||||
| Series C | Aug 19, 2021 | ||||
| Series B | Apr 7, 2021 | ||||
| Series A | Oct 27, 2020 |
Key People
Founding team and executive leadership
Abogen Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series C, Series B |
| Oriental Spring Capital | Series C |
| Alwin Capital | Series C |
| Jifeng Ventures | Series B |
| BioTrack Capital | Series C, Series B |
| Loyal Valley Capital | Series C |
| SoftBank Investment Advisers | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 3841% MoM, reaching 2.7K.
- Apr 21, 2026
Phase I results for mRNA T-cell engager ABO2203 presented at AACR Annual Meeting.
Abogen Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abogen Biosciences's valuation, stock price, and market status.
